Trade Report: Today, Israel Chemicals Ltd. (ICL) Releases Earnings Results, Hits Expectations

Today, Israel Chemicals Ltd. (ICL) Releases  Earnings Results, Hits Expectations

Israel Chemicals Ltd. (NYSE:ICL) released its quarterly earnings data on Wednesday. The company reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09. The firm earned $1.38 billion during the quarter. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. Israel Chemicals’s revenue for the quarter was up .3% on a year-over-year basis. During the same period in the previous year, the business posted $0.12 EPS.

Shares of Israel Chemicals (NYSE:ICL) opened at 3.80 on Friday. The company’s 50-day moving average price is $3.74 and its 200-day moving average price is $3.99. Israel Chemicals has a 52-week low of $3.52 and a 52-week high of $5.23. The firm has a market cap of $4.84 billion, a PE ratio of 11.99 and a beta of 1.14.

Separately, Zacks Investment Research raised Israel Chemicals from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th.

Several hedge funds have recently modified their holdings of the stock. First Eagle Investment Management LLC boosted its stake in shares of Israel Chemicals by 0.3% in the second quarter. First Eagle Investment Management LLC now owns 29,583,977 shares of the company’s stock valued at $114,362,000 after buying an additional 97,067 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Israel Chemicals by 1.5% in the second quarter. Vanguard Group Inc. now owns 8,841,883 shares of the company’s stock valued at $34,484,000 after buying an additional 131,595 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of Israel Chemicals during the second quarter valued at approximately $11,135,000. Allianz Asset Management AG boosted its stake in shares of Israel Chemicals by 67.0% in the second quarter. Allianz Asset Management AG now owns 2,020,656 shares of the company’s stock valued at $7,829,000 after buying an additional 810,656 shares during the last quarter. Finally, Foyston Gordon & Payne Inc boosted its stake in shares of Israel Chemicals by 0.8% in the second quarter. Foyston Gordon & Payne Inc now owns 2,008,715 shares of the company’s stock valued at $7,834,000 after buying an additional 16,631 shares during the last quarter. Institutional investors own 6.51% of the company’s stock.

Related posts

Leave a Comment